A prospective study comparing the pharmacokinetics, efficacy, and side effects of sunitinib in patients with advanced renal cell carcinoma
Not Applicable
- Conditions
- Renal cell carcinoma
- Registration Number
- JPRN-UMIN000014685
- Lead Sponsor
- Department of Urology, Osaka International Cancer Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with serious illness in kidney, liver, heart, or hematogenous function 2. Disqualified by a medical doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relationship between trough concentrations of sunitinib and side effects
- Secondary Outcome Measures
Name Time Method Relationship between trough concentrations of sunitinib and efficacy